Sections
| Title | Starting Page | Number of Pages |
|---|
| Overview | 1 | 1 |
| Business model | 1 | 1 |
| Final equity raise and EXIM loan to fund commercialisation | 1 | 1 |
| Base-case DCF valuation is $1.10/share (previously $1.16) | 1 | 1 |
| Table/Chart: Historical earnings and RaaS’ forecasts (in A $m unless otherwise stated) | 1 | 1 |
| Table/Chart: Share Details | 1 | 1 |
| Graph: Share Performance (12 months) | 1 | 1 |
| Capital Raise Ends Strategic Round | 2 | 1 |
| EXIM Loan Now Executed | 2 | 1 |
| Earnings Forecast Changes | 2 | 1 |
| Table/Chart: Exhibit 1: Earnings adjustments FY25f-FY27f (in A $m unless otherwise stated) | 3 | 1 |
| Peer Comparison | 3 | 1 |
| Table/Chart: Exhibit 2: Peer multiples | 3 | 1 |
| DCF Valuation | 3 | 1 |
| Table/Chart: Exhibit 3: DCF valuation (in A $m unless otherwise stated) | 4 | 1 |
| Table/Chart: Exhibit 4: Financial Year Financial Summary | 5 | 1 |
| Table/Chart: Exhibit 5: Calendar Year Financial Summary | 6 | 1 |
| FINANCIAL SERVICES GUIDE | 7 | 1 |
| RaaS Research Group Pty Ltd | 7 | 1 |
| Corporate Authorised Representative, number 1248415, of | 7 | 1 |
| About Us | 7 | 1 |
| Our general advice service | 7 | 1 |
| How are we paid? | 7 | 1 |
| Associations and Relationships | 7 | 1 |
| Complaints | 7 | 1 |
| Professional Indemnity Insurance | 7 | 1 |
| Disclosure | 8 | 1 |
